Back to Search
TAREK MEKHAIL, M.D.
M.D.
Hematology & Oncology Physician
NPI: 1447214911IndividualAccepts Medicare
Specialties, Licenses & Credentials
Hematology & Oncology PhysicianPrimary
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
35073938M(OH)ME103100(FL)
CMS Specialties
PrimaryHEMATOLOGY/ONCOLOGY
Education
OTHER
Class of 1984
Research & Publications (20)
Investigational agents in the management of non-small cell lung cancer.
PMID 19508832·Curr Oncol Rep·2009
6-review
A phase I study with neratinib (HKI-272), an irreversible pan ErbB receptor tyrosine kinase inhibitor, in patients with solid tumors.
PMID 19318484·Clin Cancer Res·2009
3-trial
A comparison of two stereotactic body radiation fractionation schedules for medically inoperable stage I non-small cell lung cancer: the Cleveland Clinic experience.
PMID 19633473·J Thorac Oncol·2009
4-observational
Gender, race, and survival: a study in non-small-cell lung cancer brain metastases patients utilizing the radiation therapy oncology group recursive partitioning analysis classification.
PMID 19327899·Int J Radiat Oncol Biol Phys·2009
8-other
Metastatic sarcomatoid renal cell carcinoma treated with vascular endothelial growth factor-targeted therapy.
PMID 19064974·J Clin Oncol·2009
8-other
Phase I trial of weekly docetaxel and daily temozolomide in patients with metastatic disease.
PMID 18626572·Invest New Drugs·2008
3-trial
Antitumor effects of sunitinib or sorafenib in patients with metastatic renal cell carcinoma who received prior antiangiogenic therapy.
PMID 17997441·J Urol·2008
8-other
Phase I trial of PEG-interferon and recombinant IL-2 in patients with metastatic renal cell carcinoma.
PMID 17909807·Cancer Chemother Pharmacol·2008
3-trial
ProApolipoprotein A1: a serum marker of brain metastases in lung cancer patients.
PMID 18257091·Cancer·2008
8-other
Sunitinib-induced macrocytosis in patients with metastatic renal cell carcinoma.
PMID 18618496·Cancer·2008
8-other
Utility of positron emission tomography compared with mediastinoscopy for delineating involved lymph nodes in stage III lung cancer: insights for radiotherapy planning from a surgical cohort.
PMID 18374513·Int J Radiat Oncol Biol Phys·2008
8-other
Thyroid function test abnormalities in patients with metastatic renal cell carcinoma treated with sorafenib.
PMID 17962201·Ann Oncol·2008
8-other
Phase I/II trial of 5-fluorouracil and a noncytotoxic dose level of suramin in patients with metastatic renal cell carcinoma.
PMID 18824429·Clin Genitourin Cancer·2008
3-trial
Phase II trial of thalidomide as maintenance therapy for extensive stage small cell lung cancer after response to chemotherapy.
PMID 17328989·Lung Cancer·2007
3-trial
Leg weakness in a 66-year-old woman: a common presentation of an uncommon disease.
PMID 17373344·Cleve Clin J Med·2007
5-case
A phase I pharmacokinetic and pharmacodynamic study of s-3304, a novel matrix metalloproteinase inhibitor, in patients with advanced and refractory solid tumors.
PMID 17404091·Clin Cancer Res·2007
3-trial
Phase II study of gemcitabine and cisplatin in patients with previously untreated extensive stage small cell lung cancer: Southwest Oncology Group Study 9718.
PMID 17473660·J Thorac Oncol·2007
3-trial
Lung cancer screening: is it time for a change in policy?
PMID 17569202·Cleve Clin J Med·2007
6-review
Diagnosis of lung cancer by the analysis of exhaled breath with a colorimetric sensor array.
PMID 17327260·Thorax·2007
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 2501 N ORANGE AVE, SUITE 689
ORLANDO, FL 32804 - Phone
- (407) 265-6627
Quick Facts
- NPI
- 1447214911
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 42
- Publications
- 20
Are you this provider?
Claim Your Profile